Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report

Michihiro Maruyama, Takehide Asano, Takashi Kenmochi, Osamu Kainuma, Kotaro Iwasaki, Hideaki Miyauchi, Kenichi Saigo, Fumihiko Miura, Susumu Kobayashi, Takenori Ochiai

研究成果: Article

9 引用 (Scopus)

抜粋

Background: Radiofrequency ablation (RFA) is one of the standard percutaneous therapies for hepatocellular carcinoma (HCC), but RFA has not been applied to treat bone metastasis from HCC. Case: A 65-year-old male patient, who underwent hepatectomy for HCC two and a half years previously, complained of pain in his right thigh. Imaging modalities and a needle biopsy revealed metastatic HCC in his right acetabulum. The first RFA therapy was attempted under computed tomography (CT) guidance with 42 Gy radiation therapy. The second RFA therapy was performed for tumor recurrence in his pelvis at 4 years after the first RFA. Conclusion: RFA is a safe, easy, repeatable and effective therapy and should be one of the most important therapeutic modalities for bone metastasis from HCC.

元の言語English
ページ(範囲)2987-2989
ページ数3
ジャーナルAnticancer research
23
発行部数3 C
出版物ステータスPublished - 01-05-2003
外部発表Yes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Maruyama, M., Asano, T., Kenmochi, T., Kainuma, O., Iwasaki, K., Miyauchi, H., Saigo, K., Miura, F., Kobayashi, S., & Ochiai, T. (2003). Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: Case report. Anticancer research, 23(3 C), 2987-2989.